CAROLINE ROBINSON: Open Payments
NPI 1114506359 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 26 payments from 13 companies in 2025. Trend: 2023 $272 · 2024 $628 · 2025 $521
Food & beverage: $501Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Lilly USA, LLC | 3 | $66 |
| Exact Sciences Corporation | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| PFIZER INC. | 2 | $34 |
| Amgen Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: Wegovy, Kerendia, Cologuard Collection Kit, LEQVIO, KISUNLA, Auvelity, BREZTRI, REXULTI.
Industry payments across MO — which companies pay providers there.
